Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Science evolves as both controlled clinical research and real-world evidence show us how to use health care technologies to ...

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the biotech stocks to buy according to Wall Street analysts. On July 29, Apellis announced that the US FDA approved EMPAVELI (pegcetacoplan) as the ...

Discover key takeaways from Moderna's Q2 2025 earnings call, including FDA approvals, cost reductions, pipeline strategies, and financial updates.

The FDA is requiring safety labeling changes to all opioid painkillers, to better highlight the risks posed by using the ...

The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant ...

AI and semiconductor stocks are overvalued and shifting to healthcare stocks like Eli Lilly and Company could be wise. Click ...

The new wearable technology can assess multiple cardiovascular metrics, including electrical impulses and blood flow, to alert patients and clinicians to worsening heart failure and other conditions.

US FDA grants orphan drug designation to Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns to treat multiple myeloma: Paris Friday, August 1, 2025, 09:00 Hrs [IST] The US ...

From new payload linkers to artificial intelligence partnerships, advances in ADC pipelines push forward selective cancer therapies that minimize side effects.

Cardiosense receives US FDA 510(k) clearance for its CardioTag device: Chicago Friday, August 1, 2025, 17:00 Hrs [IST] Cardiosense, a medical AI company transforming cardiovascula ...

Carlsmed (Nasdaq:CARL) today announced new technology add-on payment (NTAP) reimbursement for its spine implant technology.